Derma Sciences to Complete Enrollment in DSC127 Phase 2 Wound Healing Trial This Month.
Business Wire › September 14, 2010
Linked as:
Extract
Derma Sciences to Complete Enrollment in DSC127 Phase 2 Wound Healing Trial This Month.
Top-line Efficacy Results to be Available Late December/Early January
PRINCETON, N.J. -- Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening i...See the full content of this document
Sponsored links
